跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HYDROMORPHONE HYDROCHLORIDE INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
HYDROMORPHONE HYDROCHLORIDE INJECTION USP
Authorized
STANDARD
HYDROMORPHONE HYDROCHLORIDE INJECTION USP
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
112d082438c79b6d
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
112d082438c79b6d
Drug Approval Canada Name
HYDROMORPHONE HYDROCHLORIDE INJECTION USP
Product Name
HYDROMORPHONE HYDROCHLORIDE INJECTION USP
Status
Marketed
Status Date
2022-08-24
Original Market Date
2022-08-24
Din
02514435
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous , Intramuscular , Subcutaneous
Schedule
Narcotic (CDSA I)
Ahfs
28:08.08
Atc Original
N02AA03 HYDROMORPHONE
Atc Name
n 02 aa 03
Aig Number
0108698004
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
HYDROMORPHONE HYDROCHLORIDE
1 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
112d082438c79b6d
Type
Standard
Back to Health Canada Approvals